991 ST101, an inhibitor of the transcription factor C/EBPß, promotes an immune-active tumor microenvironment in a window of opportunity (WoO) study of patients with glioblastoma (GBM)

Iwamoto, F., Rotolo, J. A., Abbate, F., Scuoppo, C., Levrero, C., Buerki, R. a, Dalahmah, O. A., & Haras, A. V. (2024). 991 ST101, an inhibitor of the transcription factor C/EBPß, promotes an immune-active tumor microenvironment in a window of opportunity (WoO) study of patients with glioblastoma (GBM). Regular and Young Investigator Award Abstracts, A1111–A1112. https://doi.org/10.1136/jitc-2024-sitc2024.0991
Authors:
Fábio M. Iwamoto
Jimmy A. Rotolo
Franco Abbate
Claudio Scuoppo
Clara Levrero
Robin a Buerki
Osama Al‐Dalahmah
Abi Vainstein Haras
Affiliated Authors:
Clara Levrero
Osama Al‐Dalahmah
Columbia Affiliation:
Subjects:
Cancer Immunotherapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2024-sitc2024.0991
DOI:
10.1136/jitc-2024-sitc2024.0991
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: